Screening for Barrett's esophagus

Gastroenterology

Volumn 148, Issue 5, 2015, Pages 912-923

  Di Pietro, Massimiliano ^a   Chan, Daniel ^b   Fitzgerald, Rebecca C ^a   Wang, Kenneth K ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MAYO CLINIC   (United States)

Author keywords

Biomarkers; Biophotonics; Cytology; Endoscopy; FISH

Indexed keywords

MICRORNA; BIOLOGICAL MARKER;

BARRETT ESOPHAGUS; BLOOD ANALYSIS; BLOOD SAMPLING; CANCER SCREENING; CAPSULE ENDOSCOPY; CELL CULTURE; CLINICAL STUDY; CONFOCAL MICROSCOPY; COST EFFECTIVENESS ANALYSIS; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DYSPLASIA; ESOPHAGOSCOPE; ESOPHAGUS BIOPSY; ESOPHAGUS CANCER; ESOPHAGUS MUCOSA; FECES ANALYSIS; FECES CULTURE; FLEXIBLE GASTROSCOPE; GASTROINTESTINAL ENDOSCOPY; HEREDITY; HUMAN; INCIDENCE; MEDICAL SOCIETY; META ANALYSIS (TOPIC); MINIMALLY INVASIVE PROCEDURE; MULTICENTER STUDY (TOPIC); OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCREENING TEST; SINGLE FIBER ENDOSCOPE; TRANSNASAL ENDOSCOPY; ADENOCARCINOMA; BIOPSY; DEVICES; EQUIPMENT DESIGN; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; MASS SCREENING; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE; PROCEDURES; RISK ASSESSMENT; RISK FACTOR;

ADENOCARCINOMA; BARRETT ESOPHAGUS; BIOLOGICAL MARKERS; BIOPSY; CAPSULE ENDOSCOPY; EQUIPMENT DESIGN; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPES; ESOPHAGOSCOPY; HUMANS; MASS SCREENING; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS;

EID: 84928597147     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.02.012     Document Type: Review

References (106)

1. J.M.G. Wilson, and G. Jungner Principles and practice of screening for disease 1968 World Health Organization Geneva, Switzerland
2. M.A. Eloubeidi, A.C. Mason, and R.A. Desmond Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? Am J Gastroenterol 98 2003 1627 1633
3. H. Pohl, and H.G. Welch The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence J Natl Cancer Inst 97 2005 142 146
4. CancerResearchUK. Oesophageal cancer statistics. http://www.cancerresearchuk.org/cancer-info/cancerstats/types/oesophagus/?script=true. Accessed September 2012.
5. A.P. Thrift, and D.C. Whiteman The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends Ann Oncol 23 2012 3155 3162
6. B.J. Reid, X. Li, and P.C. Galipeau Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis Nat Rev Cancer 10 2010 87 101
7. J. Lenglinger, M. Riegler, and E. Cosentini Review on the annual cancer risk of Barrett's esophagus in persons with symptoms of gastroesophageal reflux disease Anticancer Res 32 2012 5465 5473
8. K.N. Phoa, F.G. van Vilsteren, and B.L. Weusten Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial JAMA 311 2014 1209 1217
9. N.J. Shaheen, P. Sharma, and B.F. Overholt Radiofrequency ablation in Barrett's esophagus with dysplasia N Engl J Med 360 2009 2277 2288
10. J. Lagergren, R. Bergstrom, and A. Lindgren Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma N Engl J Med 340 1999 825 831
11. I. Tramacere, C. La Vecchia, and E. Negri Tobacco smoking and esophageal and gastric cardia adenocarcinoma: a meta-analysis Epidemiology 22 2011 344 349
12. F. Turati, I. Tramacere, and C. La Vecchia A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma Ann Oncol 24 2013 609 617
13. A. Chak, H. Ochs-Balcom, and G. Falk Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction Cancer Epidemiol Biomarkers Prev 15 2006 1668 1673
14. D.M. Levine, W.E. Ek, and R. Zhang A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus Nat Genet 45 2013 1487 1493
15. Z. Su, L.J. Gay, and A. Strange Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus Nat Genet 44 2012 1131 1136
16. S.K. Bhat, D.T. McManus, and H.G. Coleman Oesophageal adenocarcinoma and prior diagnosis of Barrett's oesophagus: a population-based study Gut 64 2015 20 25
17. R.M. Zagari, L. Fuccio, and M.A. Wallander Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study Gut 57 2008 1354 1359
18. J. Ronkainen, P. Aro, and T. Storskrubb Prevalence of Barrett's esophagus in the general population: an endoscopic study Gastroenterology 129 2005 1825 1831
19. M.J. Connor, A.P. Weston, and M.S. Mayo The prevalence of Barrett's esophagus and erosive esophagitis in patients undergoing upper endoscopy for dyspepsia in a VA population Dig Dis Sci 49 2004 920 924
20. S.R. Kadri, P. Lao-Sirieix, and M. O'Donovan Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study BMJ 341 2010 c4372
21. C. Winters Jr., T.J. Spurling, and S.J. Chobanian Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease Gastroenterology 92 1987 118 124
22. J. Lagergren Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? Gut 54 suppl 1 2005 i1 i5
23. A. Chak, A. Faulx, and C. Eng Gastroesophageal reflux symptoms in patients with adenocarcinoma of the esophagus or cardia Cancer 107 2006 2160 2166
24. G.S. Dulai, S. Guha, and K.L. Kahn Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review Gastroenterology 122 2002 26 33
25. E.S. Dellon, and N.J. Shaheen Does screening for Barrett's esophagus and adenocarcinoma of the esophagus prolong survival? J Clin Oncol 23 2005 4478 4482
26. S. Bhat, H.G. Coleman, and F. Yousef Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study J Natl Cancer Inst 103 2011 1049 1057
27. T.K. Desai, J. Singh, and N. Samala The incidence of esophageal adenocarcinoma in Barrett's esophagus has been overestimated Am J Gastroenterol 106 2011 1364 1365 author reply 1365-1366
28. F. Hvid-Jensen, L. Pedersen, and A.M. Drewes Incidence of adenocarcinoma among patients with Barrett's esophagus N Engl J Med 365 2011 1375 1383
29. D.C. Farrow, T.L. Vaughan, and C. Sweeney Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer Cancer Causes Control 11 2000 231 238
30. J.H. Rubenstein, J.M. Scheiman, and S. Sadeghi Esophageal adenocarcinoma incidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies Am J Gastroenterol 106 2011 254 260
31. J.H. Rubenstein, H. Morgenstern, and H. Appelman Prediction of Barrett's esophagus among men Am J Gastroenterol 108 2013 353 362
32. J. Johansson, F. Johnsson, and B. Walther Adenocarcinoma in the distal esophagus with and without Barrett esophagus. Differences in symptoms and survival rates Arch Surg 131 1996 708 713
33. D.A. Corley, T.R. Levin, and L.A. Habel Surveillance and survival in Barrett's adenocarcinomas: a population-based study Gastroenterology 122 2002 633 640
34. J. Theisen, H.J. Stein, and H.J. Dittler Preoperative chemotherapy unmasks underlying Barrett's mucosa in patients with adenocarcinoma of the distal esophagus Surg Endosc 16 2002 671 673
35. R.C. Fitzgerald, M. di Pietro, and K. Ragunath British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus Gut 63 2014 7 42
36. S.J. Spechler, P. Sharma, and R.F. Souza American Gastroenterological Association medical position statement on the management of Barrett's esophagus Gastroenterology 140 2011 1084 1091
37. K.K. Wang, and R.E. Sampliner Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus Am J Gastroenterol 103 2008 788 797
38. J.H. Rubenstein, A. Sonnenberg, and J. Davis Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans Gastrointest Endosc 68 2008 849 855
39. J.A. Evans, D.S. Early, and N. Fukami The role of endoscopy in Barrett's esophagus and other premalignant conditions of the esophagus Gastrointest Endosc 76 2012 1087 1094
40. G.S. Cooper, T.D. Kou, and A. Chak Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends Am J Gastroenterol 104 2009 1356 1362
41. N.J. Shaheen, B.F. Overholt, and R.E. Sampliner Durability of radiofrequency ablation in Barrett's esophagus with dysplasia Gastroenterology 141 2011 460 468
42. R.E. Pouw, K. Wirths, and P. Eisendrath Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia Clin Gastroenterol Hepatol 8 2010 23 29
43. O. Pech, A. Behrens, and A. May Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus Gut 57 2008 1200 1206
44. UK National Screening Committee. Criteria for appraising the viability, effectiveness and appropriateness of a screening programme. 2009. Available at: http://www.screening.nhs.uk/criteria. Accessed February 2015.
45. J.M. Wilson, and Y.G. Jungner [Principles and practice of mass screening for disease] Bol Oficina Sanit Panam 65 1968 281 393
46. J.H. Rubenstein, J.M. Inadomi, and J.V. Brill Cost utility of screening for Barrett's esophagus with esophageal capsule endoscopy versus conventional upper endoscopy Clin Gastroenterol Hepatol 5 2007 312 318
47. P. Sharma, T.G. Morales, and R.E. Sampliner Short segment Barrett's esophagus - the need for standardization of the definition and of endoscopic criteria Am J Gastroenterol 93 1998 1033 1036
48. M.A. Kara, M. Ennahachi, and P. Fockens Detection and classification of the mucosal and vascular patterns (mucosal morphology) in Barrett's esophagus by using narrow band imaging Gastrointest Endosc 64 2006 155 166
49. A. Soni, R.E. Sampliner, and A. Sonnenberg Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective? Am J Gastroenterol 95 2000 2086 2093
50. J.M. Inadomi, R. Sampliner, and J. Lagergren Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis Ann Intern Med 138 2003 176 186
51. J.M. Barbiere, and G. Lyratzopoulos Cost-effectiveness of endoscopic screening followed by surveillance for Barrett's esophagus: a review Gastroenterology 137 2009 1869 1876
52. M.I. Canto, S. Anandasabapathy, and W. Brugge In vivo endomicroscopy improves detection of Barrett's esophagus-related neoplasia: a multicenter international randomized controlled trial (with video) Gastrointest Endosc 79 2014 211 221
53. P. Sharma, A.R. Meining, and E. Coron Real-time increased detection of neoplastic tissue in Barrett's esophagus with probe-based confocal laser endomicroscopy: final results of an international multicenter, prospective, randomized, controlled trial Gastrointest Endosc 74 2011 465 472
54. M.S. Bergholt, W. Zheng, and K.Y. Ho Fiberoptic confocal raman spectroscopy for real-time in vivo diagnosis of dysplasia in Barrett's esophagus Gastroenterology 146 2014 27 32
55. G.W. Falk Cytology in Barrett's esophagus Gastrointest Endosc Clin North Am 13 2003 335 348
56. K.R. Geisinger, L.A. Teot, and J.E. Richter A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett's esophagus Cancer 69 1992 8 16
57. A. Kumaravel, R. Lopez, and J. Brainard Brush cytology vs. endoscopic biopsy for the surveillance of Barrett's esophagus Endoscopy 42 2010 800 805
58. A.M. Rygiel, F. Milano, and F.J. Ten Kate Assessment of chromosomal gains as compared to DNA content changes is more useful to detect dysplasia in Barrett's esophagus brush cytology specimens Genes Chromosomes Cancer 47 2008 396 404
59. S.S. Robey, S.R. Hamilton, and P.K. Gupta Diagnostic value of cytopathology in Barrett esophagus and associated carcinoma Am J Clin Pathol 89 1988 493 498
60. R.H. Hardwick, R.J. Morgan, and B.F. Warren Brush cytology in the diagnosis of neoplasia in Barrett's esophagus Dis Esophagus 10 1997 233 237
61. P. Lao-Sirieix, L. Lovat, and R.C. Fitzgerald Cyclin A immunocytology as a risk stratification tool for Barrett's esophagus surveillance Clin Cancer Res 13 2007 659 665
62. M. Fahmy, M. Skacel, and T.L. Gramlich Chromosomal gains and genomic loss of p53 and p16 genes in Barrett's esophagus detected by fluorescence in situ hybridization of cytology specimens Mod Pathol 17 2004 588 596
63. A. Pacha, A.M. Rygiel, and W. Westra Novel FISH biomarker assay detects barrett progressors: a phase IV five year prospective follow up study Gastroenterology 142 2012 S-72
64. S. Anandasabapathy, S. Sontag, and D.Y. Graham Computer-assisted brush-biopsy analysis for the detection of dysplasia in a high-risk Barrett's esophagus surveillance population Dig Dis Sci 56 2011 761 766
65. J.F. Johanson, J. Frakes, and D. Eisen Computer-assisted analysis of abrasive transepithelial brush biopsies increases the effectiveness of esophageal screening: a multicenter prospective clinical trial by the EndoCDx Collaborative Group Dig Dis Sci 56 2011 767 772
66. K. Saeian, D.M. Staff, and S. Vasilopoulos Unsedated transnasal endoscopy accurately detects Barrett's metaplasia and dysplasia Gastrointest Endosc 56 2002 472 478
67. M.K. Shariff, E.L. Bird-Lieberman, and M. O'Donovan Randomized crossover study comparing efficacy of transnasal endoscopy with that of standard endoscopy to detect Barrett's esophagus Gastrointest Endosc 75 2012 954 961
68. B.A. Jobe, J.G. Hunter, and E.Y. Chang Office-based unsedated small-caliber endoscopy is equivalent to conventional sedated endoscopy in screening and surveillance for Barrett's esophagus: a randomized and blinded comparison Am J Gastroenterol 101 2006 2693 2703
69. A.F. Peery, T. Hoppo, and K.S. Garman Feasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy (with video) Gastrointest Endosc 75 2012 945 953.e2
70. E.J. Seibel, R.E. Carroll, and J.A. Dominitz Tethered capsule endoscopy, a low-cost and high-performance alternative technology for the screening of esophageal cancer and Barrett's esophagus IEEE Trans Biomed Eng 55 2008 1032 1042
71. J.M. Poneros Diagnosis of Barrett's esophagus using optical coherence tomography Gastrointest Endosc Clin North Am 14 2004 573 588
72. S.H. Yun, G.J. Tearney, and B.J. Vakoc Comprehensive volumetric optical microscopy in vivo Nat Med 12 2006 1429 1433
73. M.J. Gora, J.S. Sauk, and R.W. Carruth Tethered capsule endomicroscopy enables less invasive imaging of gastrointestinal tract microstructure Nat Med 19 2013 238 240
74. G.W. Falk, R. Chittajallu, and J.R. Goldblum Surveillance of patients with Barrett's esophagus for dysplasia and cancer with balloon cytology Gastroenterology 112 1997 1787 1797
75. M.B. Fennerty, J. DiTomasso, and T.G. Morales Screening for Barrett's esophagus by balloon cytology Am J Gastroenterol 90 1995 1230 1232
76. T. Benaglia, L.D. Sharples, and R.C. Fitzgerald Health benefits and cost-effectiveness of endoscopic and non-endoscopic cytosponge screening for Barrett's esophagus Gastroenterology 144 2013 62 73
77. E. Gultepe, S. Yamanaka, and K.E. Laflin Biologic tissue sampling with untethered microgrippers Gastroenterology 144 2013 691 693
78. R. de Franchis, E. Rondonotti, and F. Villa Capsule endoscopy - state of the art Dig Dis 25 2007 249 251
79. J.P. Galmiche, S. Sacher-Huvelin, and E. Coron Screening for esophagitis and Barrett's esophagus with wireless esophageal capsule endoscopy: a multicenter prospective trial in patients with reflux symptoms Am J Gastroenterol 103 2008 538 545
80. M. Waterman, and I.M. Gralnek Capsule endoscopy of the esophagus J Clin Gastroenterol 43 2009 605 612
81. M. di Pietro, and R.C. Fitzgerald Screening and risk stratification for Barrett's esophagus: how to limit the clinical impact of the increasing incidence of esophageal adenocarcinoma Gastroenterol Clin North Am 42 2013 155 173
82. R. Eliakim, V.K. Sharma, and K. Yassin A prospective study of the diagnostic accuracy of PillCam ESO esophageal capsule endoscopy versus conventional upper endoscopy in patients with chronic gastroesophageal reflux diseases J Clin Gastroenterol 39 2005 572 578
83. O.S. Lin, D.B. Schembre, and K. Mergener Blinded comparison of esophageal capsule endoscopy versus conventional endoscopy for a diagnosis of Barrett's esophagus in patients with chronic gastroesophageal reflux Gastrointest Endosc 65 2007 577 583
84. P. Sharma, S. Wani, and A. Rastogi The diagnostic accuracy of esophageal capsule endoscopy in patients with gastroesophageal reflux disease and Barrett's esophagus: a blinded, prospective study Am J Gastroenterol 103 2008 525 532
85. I.M. Gralnek, S.N. Adler, and K. Yassin Detecting esophageal disease with second-generation capsule endoscopy: initial evaluation of the PillCam ESO 2 Endoscopy 40 2008 275 279
86. F.C. Ramirez, R. Akins, and M. Shaukat Screening of Barrett's esophagus with string-capsule endoscopy: a prospective blinded study of 100 consecutive patients using histology as the criterion standard Gastrointest Endosc 68 2008 25 31
87. A. Bhardwaj, C.S. Hollenbeak, and N. Pooran A meta-analysis of the diagnostic accuracy of esophageal capsule endoscopy for Barrett's esophagus in patients with gastroesophageal reflux disease Am J Gastroenterol 104 2009 1533 1539
88. L. Gerson, and O.S. Lin Cost-benefit analysis of capsule endoscopy compared with standard upper endoscopy for the detection of Barrett's esophagus Clin Gastroenterol Hepatol 5 2007 319 325
89. A. Juhasz, S.K. Mittal, and T.H. Lee Prevalence of Barrett esophagus in first-degree relatives of patients with esophageal adenocarcinoma J Clin Gastroenterol 45 2011 867 871
90. G.A. Calin, and C.M. Croce MicroRNA signatures in human cancers Nat Rev Cancer 6 2006 857 866
91. P.S. Mitchell, R.K. Parkin, and E.M. Kroh Circulating microRNAs as stable blood-based markers for cancer detection Proc Natl Acad Sci U S A 105 2008 10513 10518
92. N.S. Sakai, E. Samia-Aly, and M. Barbera A review of the current understanding and clinical utility of miRNAs in esophageal cancer Semin Cancer Biol 23 2013 512 521
93. J. Kurashige, H. Kamohara, and M. Watanabe Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma J Surg Oncol 106 2012 188 192
94. S. Komatsu, D. Ichikawa, and H. Takeshita Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma Br J Cancer 105 2011 104 111
95. N.J. Fan, C.F. Gao, and X.L. Wang Tubulin beta chain, filamin A alpha isoform 1, and cytochrome b-c1 complex subunit 1 as serological diagnostic biomarkers of esophageal squamous cell carcinoma: a proteomics study OMICS 17 2013 215 223
96. N.J. Fan, C.F. Gao, and G. Zhao Serum peptidome patterns for early screening of esophageal squamous cell carcinoma Biotechnol Appl Biochem 59 2012 276 282
97. J. Xu, Y. Chen, and R. Zhang Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers Mol Cell Proteomics 12 2013 1306 1318
98. P. Kelly, F. Paulin, and D. Lamont Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer Br J Cancer 106 2012 955 961
99. H. Zou, N.K. Osborn, and J.J. Harrington Frequent methylation of eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma Cancer Epidemiol Biomarkers Prev 14 2005 830 834
100. H. Zou, J.R. Molina, and J.J. Harrington Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus Int J Cancer 116 2005 584 591
101. Z. Jin, Y. Cheng, and W. Gu A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus Cancer Res 69 2009 4112 4115
102. K. Schulmann, A. Sterian, and A. Berki Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk Oncogene 24 2005 4138 4148
103. M.A. Alvi, X. Liu, and M. O'Donovan DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett's esophagus Clin Cancer Res 19 2013 878 888
104. D.A. Corley, K. Mehtani, and C. Quesenberry Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas Gastroenterology 145 2013 312 319 e1
105. J.A. Abrams, R.C. Kapel, and G.M. Lindberg Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States Clin Gastroenterol Hepatol 7 2009 736 742
106. W.L. Curvers, F.P. Peters, and B. Elzer Quality of Barrett's surveillance in The Netherlands: a standardized review of endoscopy and pathology reports Eur J Gastroenterol Hepatol 20 2008 601 607